KR102289942B1 - Manufacturing method of jelly containing nanoparticleized medicinal herbs and the jelly prepared using the same - Google Patents
Manufacturing method of jelly containing nanoparticleized medicinal herbs and the jelly prepared using the same Download PDFInfo
- Publication number
- KR102289942B1 KR102289942B1 KR1020210009571A KR20210009571A KR102289942B1 KR 102289942 B1 KR102289942 B1 KR 102289942B1 KR 1020210009571 A KR1020210009571 A KR 1020210009571A KR 20210009571 A KR20210009571 A KR 20210009571A KR 102289942 B1 KR102289942 B1 KR 102289942B1
- Authority
- KR
- South Korea
- Prior art keywords
- jelly
- herbal medicines
- group
- lactobacillus
- herbal
- Prior art date
Links
- 235000015110 jellies Nutrition 0.000 title claims abstract description 37
- 239000008274 jelly Substances 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 235000008216 herbs Nutrition 0.000 title abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 102000008186 Collagen Human genes 0.000 claims abstract description 32
- 108010035532 Collagen Proteins 0.000 claims abstract description 32
- 229920001436 collagen Polymers 0.000 claims abstract description 32
- 239000002245 particle Substances 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 18
- 239000002002 slurry Substances 0.000 claims abstract description 12
- 238000010298 pulverizing process Methods 0.000 claims abstract description 10
- 238000002791 soaking Methods 0.000 claims abstract description 9
- 238000005406 washing Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 241000411851 herbal medicine Species 0.000 claims description 118
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 12
- 235000014655 lactic acid Nutrition 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 8
- 235000017803 cinnamon Nutrition 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims description 7
- 241000186660 Lactobacillus Species 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 229940039696 lactobacillus Drugs 0.000 claims description 6
- 241000251468 Actinopterygii Species 0.000 claims description 5
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 5
- 210000004207 dermis Anatomy 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 241000194036 Lactococcus Species 0.000 claims description 4
- 239000010975 amethyst Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- 241000186715 Lactobacillus alimentarius Species 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 3
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 3
- 241000192001 Pediococcus Species 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 240000002234 Allium sativum Species 0.000 claims description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 2
- 235000004611 garlic Nutrition 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 235000002020 sage Nutrition 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 5
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 230000036770 blood supply Effects 0.000 claims 1
- 230000001079 digestive effect Effects 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 30
- 235000013824 polyphenols Nutrition 0.000 abstract description 30
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 24
- 239000011701 zinc Substances 0.000 abstract description 24
- 229910052725 zinc Inorganic materials 0.000 abstract description 24
- 238000000605 extraction Methods 0.000 abstract description 23
- 238000010521 absorption reaction Methods 0.000 abstract description 15
- 239000002105 nanoparticle Substances 0.000 abstract description 6
- 125000000524 functional group Chemical group 0.000 abstract description 5
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 30
- 230000008569 process Effects 0.000 description 17
- 238000009837 dry grinding Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 229940124595 oriental medicine Drugs 0.000 description 8
- 241001061264 Astragalus Species 0.000 description 7
- 240000004371 Panax ginseng Species 0.000 description 7
- 235000006533 astragalus Nutrition 0.000 description 7
- 235000016213 coffee Nutrition 0.000 description 7
- 235000013353 coffee beverage Nutrition 0.000 description 7
- 238000000227 grinding Methods 0.000 description 7
- 210000004233 talus Anatomy 0.000 description 7
- 238000001238 wet grinding Methods 0.000 description 7
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 6
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 6
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 6
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 6
- 229940074393 chlorogenic acid Drugs 0.000 description 6
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 6
- 235000001368 chlorogenic acid Nutrition 0.000 description 6
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 description 5
- 244000170916 Paeonia officinalis Species 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 240000008866 Ziziphus nummularia Species 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 241000675108 Citrus tangerina Species 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 240000008058 Lilium brownii Species 0.000 description 2
- 235000015982 Lilium brownii Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004555 blood preservation Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000009616 inductively coupled plasma Methods 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 238000010409 ironing Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/25—Nanoparticles, nanostructures
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
본 발명은 나노입자화된 한약재를 포함하는 젤리의 제조 방법 및 이 방법에 의해 제조되는 젤리에 관한 것으로, 보다 구체적으로는 다수의 한약재를 작용 그룹에 따라 상이한 온도의 물로 세척 및 불림한 후 건식 분쇄하여 500㎛ 이하로 만들고, 이어서 습식 분쇄를 순차적으로 진행하여 나노 사이즈의 분말 슬러리로 만들며, 상기 나노 슬러리에 콜라겐을 혼합하여 젤리 형태로 제조함으로써, 한약재의 섭취가 용이할 뿐만 아니라 폴리페놀과 아연의 추출효율 및 체내 흡수율이 향상될 수 있도록 한 나노입자화된 한약재를 포함하는 젤리의 제조 방법 및 이 방법에 의해 제조되는 젤리에 관한 것이다.The present invention relates to a method for producing a jelly containing a nanoparticulate herbal medicine and to a jelly produced by the method, and more particularly, to a plurality of herbal medicines washed and soaked with water at different temperatures according to functional groups, followed by dry grinding to make it less than 500 μm, and then sequentially wet grinding to make a nano-sized powder slurry. It relates to a method for manufacturing a jelly containing a nanoparticulated herbal medicine so that extraction efficiency and absorption rate in the body can be improved, and to a jelly produced by the method.
한약은 보통 생약을 달인 액을 말하는데, 경우에 따라서는 생약을 산제로 하거나, 환약으로 만들기도 한다. 따라서, 한약을 복용하기 위해서는 생약을 달여야 하는 등의 불편함이 있을 뿐만 아니라, 약초를 달여 낸 액제나 생약 가루 등을 복용하게 되면 한약 특유의 쓴맛이나 냄새로 인하여 복용하기 힘들거나 어렵다는 문제가 있어왔다.Herbal medicine usually refers to a decoction of a crude drug, but in some cases, the herbal medicine is made into powder or made into pills. Therefore, in order to take herbal medicines, not only there are inconveniences such as having to decoction herbal medicines, but also there is a problem that it is difficult or difficult to take due to the bitter taste or smell peculiar to herbal medicines when taking herbal medicine powders or liquid preparations made with decoctions of medicinal herbs. .
또한, 종래에는 이러한 한약재를 적당한 크기로 절단하고 건조시킨 후 다려서 액상의 탕으로 먹었다. 이러한 고온 열량 추출 방식으로 한약재를 다려서 먹게 되면, 한약재에 함유된 각종 약리성분들의 추출율이 저하되어 한약재의 효과가 제대로 구현되기 어렵고, 특히 한약재의 성분 중에서 폴리페놀과 아연의 추출율이 크게 낮아지는 문제가 있었다.In addition, in the prior art, these herbal medicines were cut to an appropriate size, dried, ironed, and eaten as a liquid soup. When herbal medicines are ironed and eaten with this high-temperature calorie extraction method, the extraction rate of various pharmacological components contained in the herbal medicines is lowered, making it difficult to properly realize the effects of herbal medicines. there was.
이러한 종래의 한약재로 다린 탕은 맛이 쓰고 다리는 과정이 복잡하고 번거롭기 때문에 한의원이나 한약재를 다려주는 곳에 의뢰하여 다려 먹어야 하고, 취식할 때에도 맛이 쓰기 때문에 복용이 어렵고 특히 어린이의 경우 복용을 꺼리게 되는 문제가 있었다.Since the traditional herbal soup has a bitter taste and the ironing process is complicated and cumbersome, it must be ironed at an oriental medicine clinic or a place that irons oriental medicines. There was a problem.
뿐만 아니라 미리 달여 놓는 한약의 경우 보존 및 안정성에 문제가 발생할 수도 있다. 근래 들어 이러한 문제점을 해결하고자 한약에서 추출한 추출물, 생약분말 등을 산제나 과립제, 정제 또는 액제 등의 한방제제로 만들어 복용함으로써 많은 불편이 개선되어 왔고, 보존의 안정성 면에서도 우수해지게 되었다.In addition, in the case of pre-cooked herbal medicines, there may be problems with preservation and stability. In recent years, in order to solve this problem, many inconveniences have been improved by making extracts and herbal powders extracted from herbal medicines into oriental medicine preparations such as powders, granules, tablets or liquids, and taking them, and the stability of preservation has also been improved.
선행문헌인 대한민국 등록특허공보 제10-1969236호는 한약으로 만든 젤리를 개시하고 있다. 그러나, 선행문헌에는 한약재를 젤리화하는 과정에서 한약재의 성분들이 파괴되는 것을 방지하고 특히 폴리페놀과 아연의 추출효율을 높이기 위한 수단이 개시되어 있지 않다.Korean Patent Publication No. 10-1969236, which is a prior document, discloses a jelly made from herbal medicine. However, the prior literature does not disclose a means for preventing the destruction of the components of the herbal medicine in the process of gelling the herbal medicine and, in particular, for increasing the extraction efficiency of polyphenols and zinc.
폴리페놀은 페놀 구조가 2개 이상으로 구성된 분자 물질이며 같은 방향족인 벤젠, 페놀, 나프탈렌, 벤조피렌과 달리 독성을 띄지 않는다. 폴리페놀의 종류로는 탄닌, 플라보노이드, 카테킨 등이 있다. 폴리페놀은 식물이 자외선, 활성 산소, 포식자 등으로부터 자신을 보호하기 위해 만드는 것이라고 알려져 있다. 그 예로는 검은 콩의 검은 색소, 녹차, 홍차 등 차의 떫은 맛 등이 있다. 그 외 붉은 와인, 맥주, 야채와 블루베리, 블랙베리, 아로니아 등의 과일에서도 섭취가 가능하다.Polyphenol is a molecular substance composed of two or more phenol structures and is not toxic, unlike benzene, phenol, naphthalene, and benzopyrene, which are the same aromatic. Polyphenols include tannins, flavonoids, and catechins. It is known that polyphenols are produced by plants to protect themselves from UV rays, reactive oxygen species, and predators. Examples include the black pigment of black beans, green tea, and black tea, such as the astringent taste of tea. You can also consume red wine, beer, vegetables and fruits such as blueberries, blackberries, and aronia.
또한, 폴리페놀은 항산화 물질로서 신체 전반의 건강 및 혈관, 피부 등에 도움을 준다. 일본 국립 암연구센터에서는 커피를 하루 1잔 내지 3잔을 마시면 간암 발병률이 70%(3잔) 정도 줄어든다고 밝혔다.In addition, polyphenols, as antioxidants, help the overall health of the body, blood vessels, and skin. According to the National Cancer Research Center in Japan, drinking 1 to 3 cups of coffee a day reduces the risk of liver cancer by 70% (3 cups).
하루에 커피 3잔을 마시면 사망 위험이 반으로 줄어든다는 연구 결과(고려대)와 커피 3 내지 5잔을 마시면 3 내지 7년을 더 오래 산다는 연구 결과(하버드대, 남4만 명 여16만 명을 30년간 연구)도 있다. 커피를 1-2잔 혹은 6잔 이상 마시면 이런 효과가 없는데, 사실 이것은 커피의 효과가 아니라 폴리페놀의 효과라고 봐야 한다. 차는 커피와는 다르게 카테킨 성분이 적극적으로 카페인이 체내 흡수되는 것을 막기 때문에 커피보다는 카페인의 부작용을 덜 주의해도 된다.A study found that drinking 3 cups of coffee a day reduced the risk of death by half (Korea University) and a study that found that drinking 3 to 5 cups of coffee lived 3 to 7 years longer (Harvard University, 40,000 males and 160,000 females) 30 years of research). Drinking more than 1-2 cups or 6 cups of coffee does not have this effect. In fact, this is not the effect of coffee, but the effect of polyphenols. Unlike coffee, tea and catechins actively prevent caffeine from being absorbed into the body, so you need to be less careful about the side effects of caffeine than coffee.
아연은 생물체 내에서 2가 양이온으로 존재하고, 생물의 핵산과 아미노산 대사에 반드시 필요한 무기 물질이자 지각을 이루는 중요 원소이다. 이러한 아연은 소화와 호흡은 물론, 인슐린 작용과 면역기능, 생식 세포에도 관여한다.Zinc exists as a divalent cation in living things, and is an essential inorganic material for nucleic acid and amino acid metabolism of living things, and an important element forming the earth's crust. Zinc is involved in digestion and respiration, as well as insulin action, immune function, and reproductive cells.
또한, 아연은 단백질 신진 대사에도 관여하며 뼈를 단단하게 하는 작용도 있다. 그리고 남성호르몬과 근육, 정자 생성, 피부 미용에도 아연이 많은 관여를 한다. 또한, 아연이 부족할 시 탈모의 원인이 될 수도 있다. 다만, 아연의 흡수율은 40% 이하로 상당히 낮은데, 식약처에서 권장하는 아연 1일 권장량은 10~20mg이고, WHO에서는 남성 30~60mg, 여성 30~45mg으로 정하고 있다.In addition, zinc is also involved in protein metabolism and has the effect of strengthening bones. And male hormone, muscle, sperm, production, and zinc are also involved in skin beauty. Also, zinc deficiency can cause hair loss. However, the absorption rate of zinc is quite low, less than 40%. The daily recommended amount of zinc recommended by the Ministry of Food and Drug Safety is 10-20 mg, and the WHO has set it as 30-60 mg for men and 30-45 mg for women.
본 발명의 목적은, 섭취가 용이할 뿐만 아니라 최종 제품에서의 폴리페놀과 아연의 추출효율 및 섭취시 체내 흡수율을 향상시키기 위해 한약재를 초미세분말화시킨 나노입자화된 한약재를 포함하는 젤리의 제조 방법 및 이 방법에 의해 제조되는 젤리를 제공하는데 있다.It is an object of the present invention to produce jelly containing nanoparticulate herbal medicines obtained by refining oriental medicines into ultra-fine powders to improve the extraction efficiency of polyphenols and zinc in the final product and absorption rate in the body upon ingestion as well as easy ingestion. To provide a method and a jelly produced by the method.
본 발명의 일 측면은, 다수의 한약재를 작용 그룹에 따라 냉수, 미온수 및 온수 중 하나로 세척 및 불림한 후, 건식 분쇄하여 최대 입자 직경이 500㎛ 이하의 1차 분쇄물을 마련하는 제1 단계; 상기 1차 분쇄물에 정제수를 주입하고 습식 분쇄하여 나노 사이즈의 분말 슬러리로 이루어진 2차 분쇄물을 마련하는 제2 단계; 및 상기 2차 분쇄물에 콜라겐을 혼합하여 젤리 형태로 만드는 제3 단계; 를 포함하는 것을 특징으로 하는 나노입자화된 한약재를 포함하는 젤리의 제조 방법을 제공한다.One aspect of the present invention provides a first step of washing and soaking a plurality of herbal medicines with one of cold water, tepid water, and hot water according to a functional group, followed by dry grinding to prepare a primary pulverized product having a maximum particle diameter of 500 μm or less; a second step of injecting purified water into the first pulverized material and wet pulverizing to prepare a second pulverized product made of a nano-sized powder slurry; and a third step of mixing collagen with the secondary pulverized product to form a jelly; It provides a method for producing a jelly containing a nanoparticulated herbal medicine, characterized in that it comprises a.
본 발명의 바람직한 특징에 의하면, 상기 한약재 중에서 씨앗 또는 뿌리에 해당하는 한약재는 세척 및 불림을 하기 전에 파쇄하는 과정을 먼저 진행할 수 있다.According to a preferred feature of the present invention, the herbal medicines corresponding to seeds or roots among the herbal medicines may be crushed before washing and soaking.
본 발명의 바람직한 특징에 의하면, 상기 한약재 중에서, 면역 작용을 하는 제1 그룹의 한약재는 냉수로 세척 및 불림을 하고, 보혈 작용을 하는 제2 그룹의 한약재는 미온수로 세척 및 불림을 하고, 소화 작용을 하는 제3 그룹의 한약재는 온수로 세척 및 불림을 할 수 있다.According to a preferred feature of the present invention, among the herbal medicines, the first group of herbal medicines having an immune action are washed and soaked with cold water, and the herbal medicines of the second group that have a blood-holding action are washed and soaked with lukewarm water, and digestion is performed. Herbal medicines of the third group that do this can be washed and soaked with hot water.
본 발명의 바람직한 특징에 의하면, 상기 제1 단계는, 한약재를 건식 분쇄하기 전에, 세척 및 불림된 한약재를 온풍 건조한 후, 1 내지 2분간 급속 냉동 동결할 수 있다.According to a preferred feature of the present invention, in the first step, before dry pulverizing the herbal medicine, the washed and soaked herbal medicine is dried with hot air, and then rapidly frozen and frozen for 1 to 2 minutes.
본 발명의 바람직한 특징에 의하면, 상기 2차 분쇄물의 평균 입자 직경이 100 내지 200nm일 수 있다.According to a preferred feature of the present invention, the secondary pulverized product may have an average particle diameter of 100 to 200 nm.
본 발명의 바람직한 특징에 의하면, 상기 제2 단계는, 상기 1차 분쇄물을 회전식 로킹 믹서(rotator rocking mixer)에 주입하고 30분간 반응시킨 후, 플레인터리 로터 밀(planetary rotor mill)의 반응용기(bowl)에 넣고 추가로 회전시키되, 상기 플레인터리 로터 밀은, 최초 1분 동안은 100rpm부터 500rpm까지 속도를 높이면서 회전시킨 후, 약재 100ml당 30 내지 50ml의 정제수를 주입하여 습식 상태로 전환하고, 회전 속도를 800rpm까지 증가시켜 2분간 더 회전시켜 슬러리로 이루어진 2차 분쇄물을 마련할 수 있다.According to a preferred feature of the present invention, in the second step, the primary pulverized material is injected into a rotary rocking mixer and reacted for 30 minutes, followed by a reaction vessel of a planetary rotor mill ( bowl) and additionally rotated, the planetary rotor mill is rotated while increasing the speed from 100 rpm to 500 rpm for the first 1 minute, and then 30 to 50 ml of purified water per 100 ml of medicinal material is injected into a wet state, By increasing the rotation speed to 800 rpm and further rotating for 2 minutes, a secondary pulverized product made of a slurry can be prepared.
본 발명의 바람직한 특징에 의하면, 제1항에 있어서, 상기 제3 단계에서, 상기 콜라겐은, 어류의 지느러미를 단백질 분해 효소로 1차 가수 분해하여 분자량이 500 내지 1000이 되는 콜라겐을 포함하는 1차 가수분해물을 마련하고, 상기 1차 가수분해물에 유산균을 혼합하고 2차 가수 분해하여 상기 1차 가수분해물 보다 분자량이 더 낮아진 2차 가수분해물을 마련하고, 상기 2차 가수분해물을 정제 및 건조하여 얻어지는 분자량이 100 내지 400인 콜라겐 펩타이드일 수 있다.According to a preferred feature of the present invention, according to a preferred feature of the present invention, in the third step, the collagen comprises collagen whose molecular weight is 500 to 1000 by first hydrolyzing the fin of a fish with a proteolytic enzyme. Obtained by preparing a hydrolyzate, mixing lactic acid bacteria with the primary hydrolyzate, and performing secondary hydrolysis to prepare a secondary hydrolyzate having a lower molecular weight than the primary hydrolyzate, and purifying and drying the secondary hydrolyzate It may be a collagen peptide having a molecular weight of 100 to 400.
본 발명의 다른 측면은, 상기의 제조 방법에 의해 제조되는 나노입자화된 한약재를 포함하는 젤리를 제공한다.Another aspect of the present invention provides a jelly comprising a nanoparticulated herbal medicine prepared by the above manufacturing method.
본 발명의 일 실시 예에 따르면, 다수의 한약재를 작용 그룹에 따라 상이한 온도의 물로 세척 및 불림한 후 건식 분쇄하고, 이어서 나노 사이즈의 분말 슬러리로 습식 분쇄하며, 초미세분말로 습식 분쇄된 한약 입자에 저분자 콜라겐을 혼합하여 젤리화 함으로써, 한약재를 젤리 형태로 간편하게 섭취할 수 있을 뿐만 아니라 제조 과정에서 폴리페놀과 아연의 파괴를 방지하여 최종 제품에서의 폴리페놀과 아연의 추출효율을 향상시킬 수 있고, 한약재의 유효 성분이 체내에 보다 효과적으로 흡수될 수 있도록 하는 효과가 있다.According to an embodiment of the present invention, a plurality of herbal medicines are washed and soaked with water at different temperatures depending on the functional group, then dry-pulverized, then wet-pulverized into a nano-sized powder slurry, and wet-pulverized into ultra-fine powders. By mixing low-molecular collagen in the gel to form a jelly, not only can the herbal medicines be easily ingested in the form of jelly, but also it is possible to prevent the destruction of polyphenols and zinc during the manufacturing process, thereby improving the extraction efficiency of polyphenols and zinc in the final product. , it has the effect of allowing the active ingredients of herbal medicines to be more effectively absorbed into the body.
도 1은 본 발명의 일 실시 예에 의한 나노입자화된 한약재를 포함하는 젤리의 제조 방법을 순서대로 나타낸 플로우차트이다.
도 2는 다수의 한약재가 혼합된 상태를 도시한 사진이다.
도 3은 다수의 한약재를 건식 분쇄한 후의 상태를 도시한 사진이다.
도 4는 건식 분쇄된 한약재를 이어서 습식 분쇄한 후의 상태를 도시한 사진이다.1 is a flowchart sequentially showing a method of manufacturing a jelly containing a nanoparticulated herbal medicine according to an embodiment of the present invention.
2 is a photograph showing a state in which a plurality of herbal medicines are mixed.
3 is a photograph showing a state after dry grinding a number of herbal medicines.
4 is a photograph showing a state after dry-pulverized herbal medicines are subsequently wet-pulverized.
이하, 본 발명의 바람직한 실시 예를 설명한다. 그러나, 본 발명의 실시 예는 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 이하 설명하는 실시 예로 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention will be described. However, embodiments of the present invention may be modified in various other forms, and the scope of the present invention is not limited to the embodiments described below.
덧붙여, 명세서 전체에서 어떤 구성요소를 '포함'한다는 것은 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있다는 것을 의미한다.In addition, 'including' a certain component throughout the specification means that other components may be further included, rather than excluding other components, unless otherwise stated.
본 실시 예에 의한 나노입자화된 한약재를 포함하는 젤리는, 한약재의 폴리페놀과 아연의 추출효율을 극대화하기 위한 방안으로서, 다수의 한약재를 주성분으로 하고, 이러한 다수의 한약재를 혼합한 후 습식 및 분쇄하여 나노화시킨 후 섭취하기 좋게 젤리화한 것이다.Jelly containing nanoparticulate herbal medicines according to this embodiment is a method for maximizing the extraction efficiency of polyphenols and zinc of herbal medicines. It is pulverized and made into a nano, and then it is made into a jelly for easy consumption.
이러한 본 발명의 나노입자화된 한약재를 포함하는 젤리를 제조하기 위해서는, 도 1에서와 같이, 먼저 다수의 한약재를 건식 분쇄하여 마이크로 사이즈로 분쇄된 1차 분쇄물을 마련한다(S10). 도 2는 건식 분쇄 전의 다수의 한약재가 혼합된 상태를 보여주는 사진이고, 도 3은 한약재 혼합물이 건식 분쇄된 후의 1차 분쇄물의 상태를 보여주는 사진이다.In order to prepare the jelly containing the nanoparticulate herbal medicine of the present invention, as in FIG. 1 , first, a plurality of herbal medicines are dry-pulverized to prepare a primary pulverized product pulverized to a micro size (S10). 2 is a photograph showing a state in which a plurality of herbal medicines are mixed before dry grinding, and FIG. 3 is a photograph showing a state of a primary pulverized product after the herbal medicine mixture is dry grinding.
본 실시 예에서 상기 다수의 한약재는 21종을 포함할 수 있다. 또한, 이러한 한약재는 후술하는 분쇄 과정에서 추출효율을 높이고 체내 흡수율을 향상시켜 인체에 대하여 최대 효과를 제공할 수 있도록 하기 위해, 건식 분쇄하기 전에 전처리 작업을 먼저 진행할 수 있다(S5).In this embodiment, the plurality of herbal medicines may include 21 kinds. In addition, in order to provide the maximum effect on the human body by increasing the extraction efficiency and improving the absorption rate in the body in the grinding process to be described later, these herbal medicines may be pre-treated prior to dry grinding (S5).
상기 전처리 작업은 한약재를 정제수로 세척 및 불림을 하는 과정일 수 있으며, 이때 각각의 한약재는 작용 그룹에 따라 냉수, 미온수 및 온수 중 하나를 이용하여 세척 및 불림을 한 후, 건식 분쇄하여 미세화하는 공정을 거쳐 마이크로 사이즈의 1차 분쇄물이 될 수 있다.The pre-treatment operation may be a process of washing and soaking herbal medicines with purified water, in which each herbal medicine is washed and soaked using one of cold water, tepid water and hot water depending on the functional group, followed by dry grinding and refinement It can be a micro-sized primary pulverized product through
상기 다수의 한약재는 효능 별로 크게 3개의 작용 그룹으로 구분할 수 있으며, 면역 작용을 하는 제1 그룹의 한약재, 보혈 작업을 하는 제2 그룹의 한약재 및 소화 작용을 하는 제3 그룹의 한약재로 구분할 수 있다.The plurality of herbal medicines can be largely divided into three action groups by efficacy, and can be divided into a first group herbal medicine for immunity, a second group herbal medicine for blood preservation, and a third group herbal medicine for digestion. .
상기 제1 그룹의 한약재로는 인동(금은화), 당개나리비늘줄기, 황금, 사삼, 홍삼 및 침향이 있다. 상기 제2 그룹의 한약재로는 백작약, 건지황, 황기 및 참당귀가 있다. 상기 제3 그룹의 한약재로는 계피, 갈근, 사인씨앗, 창출뿌리줄기, 건강, 대추, 감초, 곽향, 박하, 공사인 및 진피가 있다.The herbal medicines of the first group include ginseng (golden and ginseng), sagebrush, golden ginseng, ginseng, red ginseng and amethyst. Herbal medicines of the second group include ear peony, geonjihwang, astragalus and champignon. Herbs of the third group include cinnamon, garlic root, sage seed, rhizome, health, jujube, licorice, gwakhyang, mint, koongin and dermis.
본 실시 예에서, 1차 분쇄에 사용되는 다수의 한약재는 인동(금은화) 3-8중량%, 당개나리비늘줄기(홍콩백합비늘줄기) 4-9중량%, 황금 4-9중량%, 사삼 4-9중량%, 홍삼 4-9중량%, 침향 4-9중량%와, 작약(백작약) 4-9중량%, 건지황 4-9중량%, 황기 4-9중량%, 참당귀 4-9중량%와, 계피 4-9중량%, 갈근 4-9중량%, 사인씨앗 4-9중량%, 창출뿌리줄기 1-5중량%, 건강 1-5중량%, 대추 1-5중량%, 감초 0.3-2중량%, 곽향(배초향) 1-4중량%, 박하 3-7중량%, 공사인 1-5중량%, 진피(귤껍질) 1-5중량%를 포함할 수 있다.In this embodiment, a number of herbal medicines used for the primary grinding are 3-8% by weight of phosphorus (golden and silver), 4-9% by weight of forsythia stalk (Hong Kong lily stalk), 4-9% by weight of gold, 4 ginseng -9% by weight, red ginseng 4-9% by weight, amethyst 4-9% by weight, peony (pearl yak) 4-9% by weight, dried turmeric 4-9% by weight, astragalus 4-9% by weight, chamomile 4-9% by weight %, cinnamon 4-9% by weight, ground root 4-9% by weight, sine seed 4-9% by weight, rhizome 1-5% by weight, health 1-5% by weight, jujube 1-5% by weight, licorice 0.3 -2% by weight, Kwakhyang (baechohyang) 1-4% by weight, peppermint 3-7% by weight, constructionin 1-5% by weight, dermis (tangerine peel) 1-5% by weight.
더 바람직하게는, 상기 다수의 한약재는, 인동(금은화) 5.7중량%, 당개나리비늘줄기(홍콩백합비늘줄기) 6.6중량%, 황금 5.9중량%, 사삼 6.4중량%, 홍삼 6.4중량%, 침향 6.4중량%와, 작약(백작약) 5.9중량%, 건지황 5.9중량%, 황기 5.9중량%, 참당귀 5.9중량%와, 계피 5.6중량%, 갈근 5.6중량%, 사인씨앗 5.6중량%, 창출뿌리줄기 3.3중량%, 건강 2.4중량%, 대추 2.4중량%, 감초 1.1중량%, 곽향(배초향) 2.5중량%, 박하 5.5중량%, 공사인 2.5중량%, 진피(귤껍질) 2.5중량%를 포함할 수 있다.More preferably, the plurality of herbal medicines include phosphorus (golden and silver) 5.7% by weight, forsythia stalk (Hong Kong lily scale stem) 6.6% by weight, gold 5.9% by weight, ginseng 6.4% by weight, red ginseng 6.4% by weight, amethyst 6.4 Weight%, Peony (Peony) 5.9% by weight, Dried Hwangchi 5.9% by Weight, Astragalus 5.9% by Weight, Black Angelica 5.9% by Weight, Cinnamon 5.6% by Weight, Root 5.6% by Weight, Sine Seed 5.6% by Weight, Genesis rhizome 3.3% by weight %, health 2.4% by weight, jujube 2.4% by weight, licorice 1.1% by weight, Kwakhyang (baechohyang) 2.5% by weight, peppermint 5.5% by weight, constructionin 2.5% by weight, dermis (tangerine peel) 2.5% by weight.
이때, 면역 작용을 하는 제1 그룹의 한약재는 음의 기운을 띠므로 이러한 특성에 맞춰 18 내지 22℃의 냉수에 주입하여 1시간 동안 정치시켜 한약재의 표면에 붙어 있는 오염물을 세척하여 제거되도록 하고, 이 과정에서 수화 작용에 의해 불림이 되어 한약재의 부피가 증가될 수 있다. 이때, 제1 그룹의 한약재를 상온의 냉수에 정치시키는 것은 한약재 내부에 포함되어 있는 성분을 보호하고 파괴되지 않도록 유지하기 위해서이다.At this time, since the first group of herbal medicines acting as immunity has negative energy, it is injected into cold water of 18 to 22 ℃ according to these characteristics and left for 1 hour to wash and remove contaminants attached to the surface of the herbal medicine, In this process, the volume of the herbal medicine may be increased by being soaked by hydration. At this time, leaving the first group of herbal medicines in cold water at room temperature is to protect the ingredients contained in the herbal medicines and keep them from being destroyed.
그리고, 보혈 작용을 하는 제2 그룹의 한약재는 제1 그룹과 제3 그룹의 한약재에 비해 중성의 특성을 가지고 있으므로 25 내지 35℃의 미온수에 주입하여 1시간 동안 정치시켜 세척 및 불림 공정을 진행할 수 있다.In addition, since the herbal medicines of the second group that act as a blood retainer have a neutral characteristic compared to the herbal medicines of the first and third groups, it is injected into lukewarm water at 25 to 35 ° C. there is.
그리고, 소화 작용을 하는 제3 그룹의 한약재는 40 내지 50℃의 온수에 주입하여 1시간 동안 정치시켜 세척 및 불림 공정을 진행할 수 있다. 이때, 제3 그룹의 한약재는 재료 특성상 단단한 재료이면서 양의 기운을 띠므로, 이러한 특성에 맞춰 세척 및 불림 효과를 높이기 위해서, 제1 및 제2 그룹의 한약재에 비해 상대적으로 높은 온도의 물에 정치시키는 것이다.In addition, the third group of medicinal herbs for digestion may be injected into hot water of 40 to 50° C. and allowed to stand for 1 hour to proceed with washing and soaking processes. At this time, since the herbal medicine of the third group is a hard material and has positive energy due to the characteristics of the material, in order to increase the washing and soaking effect according to these characteristics, it is placed in water at a relatively high temperature compared to the herbal medicine of the first and second groups. will make it
또한, 상기 한약재들 중에서 씨앗 또는 뿌리에 해당하는 한약재는 크기가 너무 크기 때문에 세척 및 불림을 하기 전에 예를 들어 절구 등으로 내려쳐서 잘게 부수는 등의 물리적인 방법을 이용하여 적당한 크기로 파쇄하는 과정을 먼저 진행하는 것이 바람직하다.In addition, the process of crushing to an appropriate size using a physical method such as crushing, for example, with a mortar before washing and soaking, because the size of the oriental medicine corresponding to the seed or root among the herbal medicines is too large It is preferable to proceed first.
여기서, 뿌리에 해당하는 한약재는 백작약, 건지황, 황기, 갈근, 창출뿌리줄기, 감초, 당귀, 사삼, 황금, 건강, 홍삼 등이 있다. 씨앗에 해당하는 한약재는 진피, 공사인, 대추육 등이 있다. 그리고, 잎에 해당하는 한약재는 계피, 곽향, 금은화, 박하, 침향 등이 있다.Here, herbal medicines corresponding to the root include ear peony, red ginseng, astragalus, red ginseng, crested rhizome, licorice, angelica, ginseng, golden, health, and red ginseng. Herbal medicines corresponding to seeds include dermis, kojiin, and jujube. And, herbal medicines corresponding to the leaves include cinnamon, gwakhyang, gold and silver flower, mint, and aloes.
그리고, 이러한 한약재는, 세척 및 불림된 상태에서 체를 이용해서 건져낸 후, 45 내지 55℃의 내부 온도를 유지하는 건조기를 이용하여 약 2시간 정도 온풍 건조시키는 과정을 거칠 수 있고, 건조가 완료된 후 1 내지 2분간 급속 냉동 동결한 후 건식 분쇄 과정을 진행할 수 있다.In addition, these herbal medicines can be dried using a sieve in a washed and soaked state, and then dried with hot air for about 2 hours using a dryer that maintains an internal temperature of 45 to 55 ° C. After drying is completed After rapid freezing and freezing for 1 to 2 minutes, a dry grinding process may be performed.
이때, 한약재를 온풍 건조한 후 건식 분쇄하는 과정에서 열이 발생하게 되는데, 이러한 열에 의해 한약재에 포함된 성분들, 특히 폴리페놀과 아연이 파괴되어 소실되는 문제가 발생할 수 있다.At this time, heat is generated in the process of dry pulverizing the herbal material after drying it with warm air. This heat may cause a problem in that the components included in the herbal medicine, in particular polyphenol and zinc, are destroyed and lost.
본 실시 예에서와 같이, 한약재를 작용 그룹에 따라 상이한 온도의 물로 각각 세척 및 불림하는 전처리 작업을 수행하면, 전처리 과정에서 한약재의 약성이 증강되는 것은 물론이고, 온풍 건조한 후에 동결하면 건식 분쇄시 과도한 마모 열이 발생하는 것을 억제하여 한약재의 폴리페놀과 아연이 소실되는 것을 방지하여 추출효율을 향상시킬 수 있다.As in this embodiment, if the pretreatment operation of washing and soaking the herbal medicines with water at different temperatures according to the working group is performed, the weakness of the herbal medicines is enhanced during the pretreatment process, and if frozen after hot air drying, excessive dry grinding is performed. It is possible to improve the extraction efficiency by preventing the loss of polyphenol and zinc in herbal medicines by suppressing the generation of heat from abrasion.
다음으로, 급속 냉동 동결된 한약재는 디스크 밀(Disk Mill)을 통해 건식 방법으로 분쇄하여 도 3에서와 같이 최대 입자 직경이 500㎛ 이하인 1차 분쇄물을 마련할 수 있다.Next, the quick-frozen oriental medicine may be pulverized by a dry method through a disk mill to prepare a primary pulverized product having a maximum particle diameter of 500 μm or less as shown in FIG. 3 .
이때, 각각의 한약재를 최대 입자 직경이 500㎛ 이하 크기가 되도록 분쇄하기 위해서는, 디스크 밀의 작업 조건이 디스크 갭(Disk gap)을 500㎛로, 디스크(Disk) 회전 속도를 350rpm으로 하여 10분간 회전을 시키게 된다.At this time, in order to pulverize each herbal medicine to have a maximum particle diameter of 500 μm or less, the working conditions of the disk mill are a disk gap of 500 μm and a disk rotation speed of 350 rpm for 10 minutes. will make it
후술하는 제2 단계의 습식 분쇄의 경우 분산기에 주입되는 재료의 분말의 최대 입자 직경이 500㎛ 이하가 되어야 한다. 또한, 처음부터 다수의 한약재를 포함하는 재료를 습식 분쇄하면, 서로 다른 입자 직경을 가진 한약재가 골고루 섞이지 않아 떡짐 현상이 발생할 수 있다.In the case of wet grinding in the second step to be described later, the maximum particle diameter of the powder of the material injected into the disperser should be 500 μm or less. In addition, when a material containing a plurality of herbal medicines is wet-grinded from the beginning, the herbal medicines having different particle diameters are not evenly mixed, which may cause a rice cake phenomenon.
본 실시 예에서는, 1차로 건식 분쇄를 통해 재료의 분말의 최대 입자 직경을 500㎛ 이하가 되도록 하면서 서로 다른 한약재의 직경을 고르게 만들 수 있고, 이에 이어지는 2차의 습식 분쇄시 떡짐 현상이 발생하는 것을 방지할 수 있다.In this embodiment, it is possible to make the diameters of different oriental medicines uniform while making the maximum particle diameter of the powder of the material 500 μm or less through dry grinding in the first place, and the occurrence of rice cakes during the second wet grinding following this can be prevented
다음으로, 상기 1차 분쇄물에 정제수를 주입하고 습식 분쇄하여 초미세분말화된 나노 사이즈의 분말 슬러리(slurry)로 이루어진 2차 분쇄물을 마련한다(S20). 이때, 상기 2차 분쇄물의 분말은 평균 입자 직경이 100 내지 200nm일 수 있다.Next, purified water is injected into the first pulverized material and wet pulverized to prepare a second pulverized product composed of an ultrafine powdered nano-sized slurry (S20). In this case, the powder of the secondary pulverized product may have an average particle diameter of 100 to 200 nm.
본 실시 예에서는, 이렇게 1차 건식 분쇄를 통해 한약재를 마이크로 사이즈로 분쇄한 후 이어서 나노 사이즈화 하는 2차 습식 분쇄를 순차적으로 진행함으로써, 한약재들이 나노 사이즈로 분쇄되는 과정에서 발생하는 열로 인해 한약재에 포함된 폴리페놀과 아연이 파괴되는 것을 방지할 수 있으며, 따라서 한약재를 제품화하는 과정에서 기존의 전탕 방식으로 추출하는 한약재에 비해 항산화 및 면역력 향상에 효과적인 폴리페놀과 아연의 추출수율을 크게 향상시킬 수 있다.In this embodiment, the herbal medicines are pulverized to a micro size through the primary dry grinding in this way, and then the secondary wet grinding of nano-size is sequentially performed. It can prevent the polyphenols and zinc contained in it from being destroyed, so it can greatly improve the extraction yield of polyphenols and zinc, which are effective for antioxidant and immunity improvement, compared to traditional herbal extracts extracted by the traditional hot water method in the process of commercializing herbal medicines. there is.
이러한 습식 분쇄 과정에 대해 보다 구체적으로 설명하면, 앞서 건식 분쇄를 통해 평균 입자 직경이 500㎛ 이하가 된 1차 분쇄물을 회전식 로킹 믹서(rotatory rocking mixer)에 주입하고, 30분간 반응시켜 다수의 한약재가 균질하게 혼합되도록 한다.To describe this wet grinding process in more detail, the primary pulverized product having an average particle diameter of 500 μm or less through dry pulverization is injected into a rotary rocking mixer and reacted for 30 minutes to react with a number of herbal medicines to be mixed homogeneously.
그리고, 균질하게 혼합된 1차 분쇄물을 플레인터리 로터 밀(planetary rotor mill)의 내부에 위치한 반응용기(bowl)에 주입하고, 각 한약재의 평균 입자 직경이 100 내지 200nm가 되도록 분산시켜 2차 분쇄물을 마련한다.Then, the homogeneously mixed primary pulverized product is injected into a reaction vessel located inside the planetary rotor mill, and dispersed so that the average particle diameter of each herbal medicine is 100 to 200 nm, followed by secondary pulverization prepare water
이때, 상기 플레인터리 로터 밀은, 500ml의 용량을 가진 2개의 반응용기(bowl)에 최대 400ml의 1차 분쇄물을 각각 주입하여, 반응용기 회전시 균형이 맞춰지도록 한다. 두 반응용기의 균형이 맞지 않으면 제대로 회전이 되지 않는다.At this time, the planetary rotor mill injects a maximum of 400 ml of the primary pulverized material into two reaction vessels having a capacity of 500 ml, respectively, so that the reaction vessel is balanced when rotating. If the two reaction vessels are out of balance, they will not rotate properly.
또한, 반응용기의 내부에는 지르코늄 성분으로 제조된 분쇄용 볼(grinding ball)을 6개씩 삽입하여, 총 12개의 분쇄용 볼을 사용할 수 있다. 이때, 상기 분쇄용 볼은 바람직하게 0.1 내지 20mm의 크기를 가질 수 있다.In addition, 6 grinding balls made of zirconium are inserted into the inside of the reaction vessel, so that a total of 12 grinding balls can be used. In this case, the grinding ball may preferably have a size of 0.1 to 20 mm.
그리고, 상기 플레인터리 로터 밀의 로터를 최초 1분 동안은 100rpm부터 500rpm까지 속도를 높이면서 회전시킨다. 이에 반응용기에 주입된 한약재가 반응용기의 내부 표면에 부착되는 것을 방지하여 분산 효율을 향상시킬 수 있다.Then, the rotor of the planetary rotor mill is rotated while increasing the speed from 100 rpm to 500 rpm for the first minute. Accordingly, it is possible to prevent the oriental medicine injected into the reaction vessel from adhering to the inner surface of the reaction vessel, thereby improving the dispersion efficiency.
이후, 약재 100ml당 30 내지 50ml의 정제수를 주입하여 분쇄물을 습식 상태로 전환시킨다. 이렇게 로터의 회전 속도를 서서히 높인 후 정제수를 주입하는 이유는, 한약재의 입자 표면의 전하에 의해 입자 간의 응집 현상이 발생하는 것을 억제하고, 전하 간 충돌에 의한 스파크의 발생을 방지하기 위함이다.Thereafter, 30 to 50 ml of purified water per 100 ml of the drug is injected to convert the pulverized product into a wet state. The reason for injecting purified water after gradually increasing the rotational speed of the rotor in this way is to suppress the occurrence of aggregation between particles due to the electric charge on the particle surface of the herbal medicine, and to prevent the occurrence of sparks due to collision between charges.
분쇄물이 습식 상태로 전환되면, 로터의 회전 속도를 800rpm까지 증가시켜 2분간 더 회전시키게 되고, 이에 반응용기의 회전 속도는 2,200rpm까지 가속도가 붙게 되면서, 도 4에서와 같이, 각 한약재의 평균 입자 직경이 100 내지 200nm의 크기로 분산되는 슬러리 상태가 된 2차 분쇄물을 마련할 수 있다.When the pulverized material is converted to a wet state, the rotation speed of the rotor is increased to 800 rpm and the rotation speed is further rotated for 2 minutes, and the rotation speed of the reaction vessel is accelerated to 2,200 rpm. A secondary pulverized product having a particle diameter of 100 to 200 nm dispersed in a slurry state may be prepared.
이때, 2차 분쇄물의 평균 입자 직경을 100nm 미만으로 하는 경우 기계설비상 제조가 어려울 뿐만 아니라 제조 비용이 지나치게 상승할 수 있다. 또한, 2차 분쇄물의 평균 입자 직경이 200nm을 초과하면 폴리페놀과 아연의 추출효율이 저하되는 문제가 발생할 수 있다.In this case, when the average particle diameter of the secondary pulverized product is less than 100 nm, manufacturing cost may be excessively increased as well as difficult to manufacture in terms of mechanical equipment. In addition, if the average particle diameter of the secondary pulverized product exceeds 200 nm, there may be a problem in that the extraction efficiency of polyphenol and zinc is lowered.
만약 2차 분쇄시 이러한 단계들을 거치지 않고, 처음부터 로터의 회전 속도를 800rpm의 최고 속도로 작동시키게 되면, 반응용기 내부에 있는 1차 분쇄물을 구성하는 한약재들이 반응용기의 내부 표면에 부착되면서 1차 분쇄물이 제대로 분산되지 않아 슬러리 상태의 2차 분쇄물로 만들기 곤란해지거나 균질성이 저하되는 등의 문제가 발생할 수 있다.If the rotational speed of the rotor is operated at the maximum speed of 800 rpm from the beginning without going through these steps during the secondary grinding, the herbal medicines constituting the primary grinding product in the reaction vessel are attached to the inner surface of the reaction vessel and 1 The secondary pulverized product is not properly dispersed, so it may be difficult to make the secondary pulverized product in a slurry state, or problems such as reduced homogeneity may occur.
또한, 1차 분쇄물의 균질성이 저하되면 후술하는 콜라겐 혼합시 콜라겐이 2차 분쇄물에 고르게 분산되지 못하게 되는데, 위와 같은 단계를 거쳐 2차 분쇄를 진행하면 이러한 문제를 해소하여 콜라겐의 분산 효과를 극대화할 수 있다.In addition, if the homogeneity of the first pulverized product is lowered, collagen cannot be evenly dispersed in the second pulverized material when the collagen is mixed, which will be described later. can do.
다음으로, 상기 2차 분쇄물을 살균기에 주입시켜 살균하고, 살균된 상기 2차 분쇄물에 콜라겐을 혼합하는 과정을 진행하여, 상기 2차 분쇄물을 섭취하기 좋은 고형의 젤리 형태가 되도록 만든다(S30).Next, the secondary pulverized product is injected into a sterilizer to sterilize, and the process of mixing collagen with the sterilized secondary pulverized product is performed to make the secondary pulverized product in the form of a solid jelly suitable for ingestion ( S30).
상기 콜라겐은 콜라겐 분말을 끓는 물에 중탕하여 액상 상태로 만들고, 이 액상의 콜라겐에 상기 살균된 2차 분쇄물을 주입한 후 회전 교반기를 이용하여 지속적으로 교반하며, 이에 2차 분쇄물과 콜라겐이 고르게 혼합되면서 젤리 형태가 되면 자동 포장 장치를 이용하여 예를 들어 1포당 20g의 젤리형 한약재로 개별 포장하여 최종 판매용 제품을 완성할 수 있다.The collagen powder is made into a liquid state by boiling the collagen powder in boiling water, and the sterilized secondary pulverized product is injected into the liquid collagen and then continuously stirred using a rotary stirrer, whereby the secondary pulverized product and collagen are mixed When mixed evenly and in the form of a jelly, the product for final sale can be completed by individually packaging, for example, 20 g of jelly-type herbal medicine per package using an automatic packaging device.
이와 같이 나노 분말 슬러리로 이루어진 2차 분쇄물에 콜라겐을 혼합하여 젤리와 같은 제형으로 만들면 개별적으로 제품화하기 용이할 뿐만 아니라 사용자가 보다 간편하게 한약재를 섭취할 수 있고 한약재로부터 추출된 폴리페놀과 아연이 인체에 흡수되는 효과 또한 향상시킬 수 있다.In this way, if collagen is mixed with the secondary pulverized material made of nanopowder slurry and made into a jelly-like formulation, it is easy to commercialize individually, and users can consume herbal medicines more conveniently, and polyphenols and zinc extracted from herbal medicines The absorption effect can also be improved.
본 실시 예에서 사용되는 콜라겐 분말은 다음과 같은 과정을 통해 마련할 수 있다.The collagen powder used in this embodiment can be prepared through the following process.
먼저 깨끗이 세척한 어류의 지느러미 등을 주성분으로 하며, 이 어류 지느러미에 단백질 분해 효소를 넣고 1차 가수 분해하여 분자량이 500 내지 1000(달톤)의 1차 가수분해물을 마련한다.First, cleanly washed fish fins are the main components, and a proteolytic enzyme is added to the fish fins for primary hydrolysis to prepare a primary hydrolyzate having a molecular weight of 500 to 1000 (Daltons).
다음으로, 상기 1차 가수분해물에 상기 1차 가수분해물 100중량부에 대하여 300중량부 이상의 유산균을 혼합하고 2차 가수 분해하여 상기 1차 가수분해물보다 상대적으로 분자량이 100 내지 400으로 더 낮아진 2차 가수분해물을 마련한다.Next, the primary hydrolyzate is mixed with 300 parts by weight or more of lactic acid bacteria with respect to 100 parts by weight of the primary hydrolyzate, and the secondary hydrolyzate has a molecular weight lower than that of the primary hydrolyzate by 100 to 400. Prepare the hydrolyzate.
상기 유산균은 락토바실러스 알리멘타리우스(Lactobacillus alimentarius), 락토바실러스 카세이(Lactobacillus Casei), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 델브루엑키(Lactobacillus delbrueckii), 락토바실러스 퍼멘텀(Lactobacillus fermentum), 페디오코커스(Pediococcus), 락토코커스(Lactococcus) 중에서 선택되는 1종 이상을 사용할 수 있다.The lactic acid bacteria are Lactobacillus Ali menta Julius (Lactobacillus alimentarius), Lactobacillus Kasei (Lactobacillus Casei), Lactobacillus biasing Li (Lactobacillus gasseri), Lactobacillus del Brewer ekki (Lactobacillus delbrueckii), Lactobacillus buffer momentum (Lactobacillus fermentum), Phedi Ococcus ( Pediococcus ), Lactococcus ( Lactococcus ) At least one selected from among may be used.
그리고, 상기 2차 가수분해물을 정제 및 건조하여 콜라겐을 마련할 수 있다.Then, the secondary hydrolyzate may be purified and dried to prepare collagen.
이때, 2차 가수 분해시 혼합된 유산균 중 1/2 이상이 미반응 유산균으로 남아 상기 콜라겐 분말이 분자량이 100 내지 400이고 풍부한 하이드록시프롤린을 갖는 저분자의 콜라겐 펩타이드로 분해된다.At this time, during the secondary hydrolysis, at least 1/2 of the mixed lactic acid bacteria remain unreacted and the collagen powder is decomposed into low molecular collagen peptides having a molecular weight of 100 to 400 and abundant hydroxyproline.
이러한 분자량이 100 내지 400인 저분자의 콜라겐 펩타이드는, 고분자의 콜라겐 보다 체내 흡수율이 높고 빠르며, 고분자 콜라겐에 포함되는 단백질 보다 폴리페놀의 체내 흡수를 덜 방해하게 된다.These low molecular weight collagen peptides having a molecular weight of 100 to 400 have a higher and faster absorption rate than high molecular weight collagen, and less interfere with the absorption of polyphenols into the body than proteins contained in high molecular weight collagen.
나아가 저분자의 콜라겐 펩타이드에 포함되는 미반응 유산균이 폴리페놀의 체내 흡수율을 높여주는 작용을 하게 되므로 본 실시 예에 의해 제조된 한약재를 포함하는 젤리를 섭취 시 폴리페놀의 체내 흡수율을 향상시키게 되며, 더불어 콜라겐의 주성분인 어류의 비린내 등을 제거하여 젤리의 상품성을 높일 수 있다.Furthermore, since unreacted lactic acid bacteria contained in the low-molecular-weight collagen peptides increase the absorption rate of polyphenols in the body, when the jelly containing the herbal medicine prepared according to this embodiment is consumed, the absorption rate of polyphenols is improved. By removing the fishy smell of fish, which is the main component of collagen, the commercial properties of jelly can be improved.
본 발명의 젤리의 경우, 저분자의 콜라겐 펩타이드에 혼합되는 미반응 유산균이 폴리페놀의 체내 흡수율을 높여주는 작용을 하여 한약재를 포함하는 젤리를 섭취시 폴리페놀의 체내 흡수율 저하를 방지할 수 있다.In the case of the jelly of the present invention, unreacted lactic acid bacteria mixed with the low molecular weight collagen peptides increase the absorption rate of polyphenols in the body, so that when the jelly containing the herbal medicine is consumed, it is possible to prevent the decrease in the absorption rate of polyphenols in the body.
본 발명에 의한 나노입자화된 한약재를 포함하는 젤리의 효과를 확인하기 위해, 종래의 고온 열량 추출법인 전탕 방식으로 추출한 한약재와 본 발명의 나노 분산화된 슬러리 타입의 한약재를 젤리화하여 폴리페놀 성분인 클로로겐산(Chlorogenic acid) 및 무기질 성분인 아연(Zn)의 추출수율을 비교하였다.In order to confirm the effect of the jelly containing the nanoparticulated herbal medicine according to the present invention, the herbal medicine extracted by the conventional high-temperature calorie extraction method and the nano-dispersed slurry-type herbal medicine of the present invention are jelly-like to form a polyphenol component. The extraction yields of chlorogenic acid and zinc (Zn), an inorganic component, were compared.
아래 표 1에서, #1 내지 #3은 비교 예이고, #4 내지 #6은 실시 예이다. 그리고, #1과 #4는 한약재로 제1 그룹의 한약재 중 하나인 인동을 사용한 것이고, #2와 #5는 한약재로 제2 그룹의 한약재 중 하나인 황기를 사용한 것이고, #3과 #6은 한약재로 제3 그룹의 한약재 중 하나인 계피를 사용한 것이다.In Table 1 below, #1 to #3 are comparative examples, and #4 to #6 are examples. And, #1 and #4 are herbal medicines that use Indong, one of the herbal medicines of the first group, #2 and #5 are Chinese medicines that use Astragalus, one of the herbal medicines of the second group, and #3 and #6 are As a herbal medicine, cinnamon, one of the herbal medicines of the third group, is used.
비교 예는 냉동 건조된 한약재 시료 1g을 취하여 잘게 자른 후 전탕 방식으로 6시간 동안 추출하고 25℃에서 진공 건조한 것이고, 실시 예는 건조된 한약재 1g을 취하여 본 발명의 제조 방법에 의한 1차 건식 분쇄 및 2차 습식 분쇄를 거친 후 저분자 콜라겐 펩타이드로 젤리화한 것이다.A comparative example is to take 1 g of a freeze-dried herbal medicine sample, cut it into small pieces, extract it in a hot water method for 6 hours, and dry it in a vacuum at 25 ° C. In an example, 1 g of dried herbal medicine is taken and the primary dry pulverization and It is made into jelly with low molecular weight collagen peptides after secondary wet grinding.
그리고, 각각의 비교 예와 실시 예에 대하여 폴리페놀인 클로로겐산 및 아연의 추출수율을 측정한다. 이때, 상기 클로로겐산은 HPLC를 통해 정량 분석하여 추출수율을 측정하고, 상기 아연의 경우 시료를 마이크로웨이브 분해법으로 전처리 한 후 유도결합플라즈마법(ICP-OES)으로 분석하여 추출수율을 측정한다.Then, the extraction yields of chlorogenic acid and zinc, which are polyphenols, are measured for each comparative example and example. At this time, the chlorogenic acid is quantitatively analyzed through HPLC to measure the extraction yield, and in the case of the zinc, the sample is pretreated by microwave decomposition method and then analyzed by inductively coupled plasma method (ICP-OES) to measure the extraction yield.
추출효율
(%)of chlorogenic acid
Extraction efficiency
(%)
추출효율 (%)zinc
Extraction efficiency (%)
표 1을 참조하면, 본 발명의 실시 예에 의해 젤리화 된 한약재(#4, 5, 6)의 경우, 비교 예(#1, 2, 3)인 전탕 방식에 의한 한약 추출물에 비해 클로로겐산의 경우 최대 16배의 추출효율을 나타내고, 아연의 경우 최대 12배의 높은 추출효율을 나타낸다.Referring to Table 1, in the case of the herbal medicine (#4, 5, 6) gelled according to the embodiment of the present invention, the case of chlorogenic acid compared to the herbal medicine extract by the hot water method of the comparative example (#1, 2, 3) The extraction efficiency is up to 16 times, and in the case of zinc, the extraction efficiency is up to 12 times higher.
이는 식물성 한약재의 내부에 포함되어 있던 폴리페놀과 아연이 나노 입자화되는 과정에서 열에 의해 파괴되지 않은 채로 나노 분산화에 의해 입자의 크기가 작게 부서지면서 쉽게 외부로 용출되었기 때문이다.This is because the polyphenols and zinc contained in the botanical herbal medicine were easily eluted to the outside as the size of the particles was broken down by the nano-dispersion without being destroyed by heat during the process of nano-particle formation.
따라서, 같은 양의 한약재를 사용하더라도 종래의 추출 방식이 아닌 본 발명의 나노 분산화 공정 및 젤리화의 공정을 거친다면 항산화 및 면역력 향상에 효과적인 폴리페놀 및 아연의 추출수율이 높아질 수 있다.Therefore, even if the same amount of herbal medicine is used, the extraction yield of polyphenols and zinc effective for antioxidant and immunity improvement can be increased if the nano-dispersion process and the gelation process of the present invention are performed instead of the conventional extraction method.
다음으로, 종래의 고온 열량 추출법인 전탕 방식으로 추출한 한약재와 본 발명의 나노 분산화된 슬러리 타입의 한약재를 젤리화하여 인체의 폴리페놀(클로로겐산) 흡수율을 확인하였다.Next, the absorption rate of polyphenols (chlorogenic acid) in the human body was confirmed by gelling the herbal medicines extracted by the conventional hot-water extraction method and the nano-dispersed slurry-type herbal medicines of the present invention.
그 결과 본 발명에서와 같이, 저분자 콜라겐 펩타이드를 이용하고 과량의 유산균을 같이 사용하면, 젤리 내 폴리페놀의 체내 흡수가 저분자 콜라겐 펩타이드에 의해 방해 받지 않고 잔류 유산균에 의해 도움을 받아서, 젤리의 폴리페놀 체내 흡수율을 전탕 방식에 비해 크게 향상시켜 같은 한약재의 양으로 종래의 전탕 방식에 비해 더 많은 양의 폴리페놀의 섭취가 가능해지는 효과를 기대할 수 있다.As a result, as in the present invention, when a low molecular weight collagen peptide is used and an excess of lactic acid bacteria is used together, the absorption of polyphenols in the body is not hindered by the low molecular weight collagen peptides but is supported by the residual lactic acid bacteria, and the polyphenols in jelly It can be expected that the absorption rate in the body is greatly improved compared to the hot water method, so that a larger amount of polyphenol can be consumed compared to the conventional hot water method with the same amount of herbal medicine.
본 발명은 상술한 실시 예 및 첨부된 도면에 의해 한정되는 것이 아니다. 따라서, 청구범위에 기재된 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 당 기술분야의 통상의 지식을 가진 자에 의해 다양한 형태의 치환, 변형 및 변경이 가능할 것이며, 이 또한 본 발명의 범위에 속한다고 할 것이다.The present invention is not limited by the above-described embodiments and the accompanying drawings. Therefore, various types of substitution, modification and change will be possible by those skilled in the art within the scope not departing from the technical spirit of the present invention described in the claims, and it is also said that it falls within the scope of the present invention. something to do.
S5: 한약재를 전처리하는 단계
S10: 한약재를 건식 분쇄하여 1차 분쇄물을 마련하는 단계
S20: 1차 분쇄물을 습식 분쇄하여 2차 분쇄물을 마련하는 단계
S30: 2차 분쇄물에 콜라겐을 혼합하여 젤리 형태로 만드는 단계S5: Step of pre-processing herbal medicines
S10: Dry-pulverizing herbal medicines to prepare a primary pulverized product
S20: Step of wet grinding the primary pulverized product to prepare a secondary pulverized product
S30: A step of mixing collagen with the secondary pulverized material to form a jelly
Claims (8)
상기 1차 분쇄물에 정제수를 주입하고 습식 분쇄하여 평균 입자 직경이 100 내지 200nm의 분말 슬러리로 이루어진 2차 분쇄물을 마련하는 제2 단계; 및
상기 2차 분쇄물에 콜라겐을 혼합하여 젤리 형태로 만드는 제3 단계; 를 포함하고,
상기 제2 단계는, 상기 1차 분쇄물을 회전식 로킹 믹서(rotator rocking mixer)에 주입하고 30분간 반응시킨 후, 플레인터리 로터 밀(planetary rotor mill)의 반응용기(bowl)에 넣고 추가로 회전시키되, 상기 플레인터리 로터 밀은, 최초 1분 동안은 100rpm부터 500rpm까지 속도를 높이면서 회전시킨 후, 약재 100ml당 30 내지 50ml의 정제수를 주입하여 습식 상태로 전환하고, 회전 속도를 800rpm까지 증가시켜 2분간 더 회전시켜 슬러리로 이루어진 2차 분쇄물을 마련하고,
상기 제3 단계에서, 상기 콜라겐은, 어류의 지느러미를 단백질 분해 효소로 1차 가수 분해하여 분자량이 500 내지 1000이 되는 콜라겐을 포함하는 1차 가수분해물을 마련하고, 상기 1차 가수분해물 100중량부에 대하여 300중량부 이상의 유산균을 혼합하고 2차 가수 분해하여 혼합된 유산균 중 1/2 이상이 미반응 유산균으로 남으면서 상기 1차 가수분해물 보다 분자량이 더 낮아진 2차 가수분해물을 마련하고, 상기 2차 가수분해물을 정제 및 건조하여 얻어지는 분자량이 100 내지 400인 콜라겐 펩타이드인 것을 특징으로 하는 나노입자화된 한약재를 포함하는 젤리의 제조 방법.A number of herbal medicines are divided into a first group that has an immune action, a second group that acts as a blood supply, and a third group that has a digestive action according to their efficacy. The herbal medicines of the group are washed and soaked with lukewarm water, and the herbal medicines of the third group are washed and soaked with hot water, then dried with hot air, rapidly frozen and frozen for 1 to 2 minutes, and then dry pulverized to a maximum particle diameter of 500 μm. A first step of preparing the following primary pulverized product;
a second step of injecting purified water into the first pulverized material and performing wet pulverization to prepare a second pulverized product comprising a powder slurry having an average particle diameter of 100 to 200 nm; and
a third step of mixing collagen with the second pulverized product to form a jelly; including,
In the second step, the primary pulverized product is injected into a rotary rocking mixer and reacted for 30 minutes, then placed in a reaction vessel of a planetary rotor mill and further rotated. , The planetary rotor mill rotates while increasing the speed from 100 rpm to 500 rpm for the first 1 minute, and then injects 30 to 50 ml of purified water per 100 ml of medicinal material to a wet state, and increases the rotation speed to 800 rpm 2 A second pulverized product consisting of a slurry is prepared by further rotating for a minute,
In the third step, the collagen is prepared by first hydrolyzing the fin of a fish with a proteolytic enzyme to prepare a primary hydrolyzate containing collagen having a molecular weight of 500 to 1000, and 100 parts by weight of the primary hydrolyzate To prepare a secondary hydrolyzate having a molecular weight lower than that of the primary hydrolyzate, while at least 1/2 of the mixed lactic acid bacteria remain as unreacted lactic acid bacteria by mixing 300 parts by weight or more of the lactic acid bacteria with respect to the secondary hydrolyzate, and A method for producing a jelly containing a nanoparticulated herbal medicine, characterized in that it is a collagen peptide having a molecular weight of 100 to 400 obtained by purifying and drying a hydrolyzate.
According to claim 1, wherein in the third step, the lactic acid bacteria mixed during the secondary hydrolysis are Lactobacillus alimentarius ( Lactobacillus alimentarius ), Lactobacillus Casei ( Lactobacillus Casei ), Lactobacillus gasseri ( Lactobacillus gasseri ), Lactobacillus Delbruecky ( Lactobacillus delbrueckii ), Lactobacillus fermentum ( Lactobacillus fermentum ), Pediococcus ( Pediococcus ), Lactococcus ( Lactococcus ) Preparation of jelly containing nanoparticulate herbal medicine, characterized in that at least one selected from the group consisting of method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210009571A KR102289942B1 (en) | 2021-01-22 | 2021-01-22 | Manufacturing method of jelly containing nanoparticleized medicinal herbs and the jelly prepared using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210009571A KR102289942B1 (en) | 2021-01-22 | 2021-01-22 | Manufacturing method of jelly containing nanoparticleized medicinal herbs and the jelly prepared using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102289942B1 true KR102289942B1 (en) | 2021-08-13 |
Family
ID=77313541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210009571A KR102289942B1 (en) | 2021-01-22 | 2021-01-22 | Manufacturing method of jelly containing nanoparticleized medicinal herbs and the jelly prepared using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102289942B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101576093B1 (en) * | 2015-06-09 | 2015-12-21 | (주)다정 | Manufacturing method of functional nanoparticle for maximizing absorption rate in the body and the nanoparticle made by the method |
KR101931359B1 (en) * | 2017-12-07 | 2018-12-20 | 농업회사법인 주식회사 주성 | Manufacturing method for jelly using barley shoot powder and nano-collagen, and jelly manufactured by the same |
KR101969236B1 (en) | 2017-11-29 | 2019-07-22 | 극동대학교 산학협력단 | Oriental Medicine Jelly and Producing Method Thereof |
KR20200004145A (en) * | 2018-07-03 | 2020-01-13 | 주식회사 바이오폴리텍 | A preparation method of collagen peptide complex derived from fish |
KR20200122729A (en) * | 2019-04-18 | 2020-10-28 | 고영인 | Processing method of coated nuts for color, flavor, and scent |
KR20200138498A (en) | 2019-05-30 | 2020-12-10 | 권현숙 | Method for rice drink using crataegus fruit and elm |
-
2021
- 2021-01-22 KR KR1020210009571A patent/KR102289942B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101576093B1 (en) * | 2015-06-09 | 2015-12-21 | (주)다정 | Manufacturing method of functional nanoparticle for maximizing absorption rate in the body and the nanoparticle made by the method |
KR101969236B1 (en) | 2017-11-29 | 2019-07-22 | 극동대학교 산학협력단 | Oriental Medicine Jelly and Producing Method Thereof |
KR101931359B1 (en) * | 2017-12-07 | 2018-12-20 | 농업회사법인 주식회사 주성 | Manufacturing method for jelly using barley shoot powder and nano-collagen, and jelly manufactured by the same |
KR20200004145A (en) * | 2018-07-03 | 2020-01-13 | 주식회사 바이오폴리텍 | A preparation method of collagen peptide complex derived from fish |
KR20200122729A (en) * | 2019-04-18 | 2020-10-28 | 고영인 | Processing method of coated nuts for color, flavor, and scent |
KR20200138498A (en) | 2019-05-30 | 2020-12-10 | 권현숙 | Method for rice drink using crataegus fruit and elm |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101999573B (en) | Method for preparing composite bee pollen health-care product | |
CN103054922B (en) | Preparation technology of panax pseudoginseng ultrafine powder granular decoction pieces | |
KR101444718B1 (en) | Tea comprising Rubus coreanus Miquel immature fruit and making method thereof | |
CN104758234A (en) | Mung bean protein composite facial mask powder and preparation method thereof | |
KR100836712B1 (en) | Cooperation material of feed using a pig breeding containted a by-product of korea raspbrry and that of method of manufacture | |
CN104323093A (en) | Stomach-invigorating digestion-helping eight-ingredient porridge and preparation method thereof | |
KR102289942B1 (en) | Manufacturing method of jelly containing nanoparticleized medicinal herbs and the jelly prepared using the same | |
CN105360872A (en) | Pitaya effervescent tablets and preparation method thereof | |
KR100904083B1 (en) | Manufacture method of hasuo tea-bag and tea-bag thereof | |
KR20160022199A (en) | Herbal sliced ginger, manufacturing method thereof, and healthy food using them | |
KR100358384B1 (en) | Health supplementary food and producing method thereof | |
CN107183593A (en) | Yunnan olive glycyrrhiza composition and its production and use | |
CN107410977A (en) | A kind of selenium-enriched food lozenge and preparation method using sweet potato stem leaf as raw material | |
CN101396056B (en) | Pine-needle tuckahoe teat and preparation method thereof | |
CN101138416B (en) | Ultra-fine edible rhodiola root albumen powder preparation method | |
KR20030004628A (en) | Manufacture method for Health Drink to Ingredient Dandelion | |
KR20100009289A (en) | Manufacturing method of jelly for promoting health having korean herbal medicines and jelly manufactured thereby | |
CN1327778C (en) | Banyan tea and preparation thereof | |
KR101071619B1 (en) | Hwakwaja for promoting health having korean herbal medicines | |
CN104904914A (en) | Fresh ginger brown sugar tea and preparation method thereof | |
KR101539282B1 (en) | Myrrha oil and manufacturing method therof | |
CN109170464A (en) | A kind of orange solid beverage of pyrus nivalis and preparation method thereof | |
KR102493333B1 (en) | Method for preparing red ginseng liquid using high shear mixer | |
KR100593469B1 (en) | A making method of herb medicine including lacquer ingredients | |
KR102485019B1 (en) | Functional leached tea and manufacturing method of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |